Plain-English translation of NCT05213429 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a registry study—meaning researchers will collect and track medical information from about 11,000 patients who have coronary artery ectasia, a condition where the blood vessels in the heart become abnormally enlarged. The study aims to understand how often this condition occurs, what treatments doctors are using, and how patients fare over one year of follow-up. This research is happening across multiple medical centers in the Middle East.
Coronary artery ectasia is a condition doctors still don't fully understand, and there's not enough clear guidance on the best way to treat it. By collecting real-world information from many patients, researchers hope to learn what treatments work best and what outcomes to expect.
You likely qualify if…
You likely don't qualify if…
If you enroll, researchers will collect information from your medical records and angiography (heart catheterization) results. You'll be followed for one year, during which the study team will track what treatments you receive and how you're doing health-wise. No new medications or procedures are being tested—this is purely an observational study gathering real-world information to better understand the condition.
AI-generated summary from trial data · Jul 4, 2026 · Not medical advice
Jordan
Sponsor
Jordanian Research and Artificial Intelligence Group
Enrollment target
~11,000 participants
Started
September 2024
Primary completion
December 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in May 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Mahmoud I Izraiq, MD, FACC, FSCAI
Jordanian Research and Artificial Intelligence Group
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.